Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma

doi:10.3748/wjg.v12.i40.6531

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2920)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

391

HTML

2266

Figures (1-5)

263

Sum=2920

Oct 28, 2006 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 28, 2006; 12(40): 6531-6535
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6531

Full Size Figure Download Figure

Figure 3 PPP was added to the medium 30 min prior to the stimulation with IGF-II (200 μg/L) and suppressed proliferation of Huh-6 and HepG2 (^aP < 0. 05).

Citation: Tomizawa M, Saisho H. Signaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma. World J Gastroenterol 2006; 12(40): 6531-6535
URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6531.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i40.6531